---
category: listing
circular_id: 5e947502fea45ee8
date: '2025-08-25'
description: BSE announces listing of 1000 bonus equity shares of Ipca Laboratories
  Ltd kept in abeyance, effective from August 26, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={6D1DFB40-1D11-45C8-8686-83C72BE613A6}&noticeno=20250825-30&dt=08/25/2025&icount=30&totcount=67&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Small number of bonus shares being released from abeyance with minimal
  market impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250825-30&attachedId=
processing:
  attempts: 1
  content_hash: b0d5b1988c315a83
  processed_at: '2025-08-25T18:40:56.834604'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-25T12:08:33+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={6D1DFB40-1D11-45C8-8686-83C72BE613A6}&noticeno=20250825-30&dt=08/25/2025&icount=30&totcount=67&flag=0
severity: low
source: bse
stocks:
- IPCA
tags:
- bonus-shares
- listing
- equity
- pharmaceutical
- abeyance
title: Listing of 1000 Bonus Equity Shares kept in abeyance of Ipca Laboratories Ltd
---

## Summary

BSE has announced the listing of 1000 bonus equity shares of Ipca Laboratories Ltd (Scrip Code: 524494) that were previously kept in abeyance. These shares will be available for trading from Tuesday, August 26, 2025.

## Key Points

- 1000 bonus equity shares of Rs. 1/- each being listed
- Shares were previously kept in abeyance
- ISIN: INE571A01038
- Distinctive numbers: 1303453 to 1304452
- Trading commences August 26, 2025

## Regulatory Changes

No regulatory changes. This is a standard listing of previously issued bonus shares.

## Compliance Requirements

Trading members are informed about the availability of these securities for trading.

## Important Dates

- **Trading Start Date**: Tuesday, August 26, 2025

## Impact Assessment

Minimal market impact due to the small number of shares (1000) relative to the company's total share capital. These bonus shares were already accounted for in previous corporate actions but were held in abeyance.